Evidence method
Level · gp.fundamentals.capex_revenue_ratio
9.02% · OPTIONAL · VALID
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME
WST · Jun 30, 2016
WEST PHARMACEUTICAL SERVICES INC. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.
STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration
State dimensions
Filing0000105770-16-000086General Corporate
Evidence method
Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
19.64% · OPTIONAL · VALID
Evidence method
Yoy · gp.fundamentals.shares_outstanding
1.69% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Yoy · gp.fundamentals.revenue
7.87% · CORE · NOT_ENOUGH_HISTORY
Evidence method
Level · gp.fundamentals.inventory_revenue_ratio
50.95% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.gross_margin
34.36% · CORE · VALID
Evidence method
Level · gp.fundamentals.operating_margin
15.77% · CORE · VALID
Evidence method
Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
2.27% · OPTIONAL · VALID
Evidence method
Level · gp.fundamentals.sbc_revenue_ratio
1.26% · OPTIONAL · VALID
As-filed lineage
Fundamental state history
Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History39 statesSelf-history eligible
Mar 31, 201910/10 normalizedLevel 3Jun 30, 201910/10 normalizedLevel 3Sep 30, 201910/10 normalizedLevel 3Dec 31, 20198/8 normalizedLevel 3Mar 31, 20209/9 normalizedLevel 3Jun 30, 20209/9 normalizedLevel 3Sep 30, 20209/9 normalizedLevel 3Dec 31, 20209/9 normalizedLevel 3Mar 31, 20219/9 normalizedLevel 3Jun 30, 20219/9 normalizedLevel 3Sep 30, 20219/9 normalizedLevel 3Dec 31, 20219/9 normalizedLevel 3Mar 31, 20229/9 normalizedLevel 3Jun 30, 20229/9 normalizedLevel 3Sep 30, 20229/9 normalizedLevel 3Dec 31, 20229/9 normalizedLevel 3Mar 31, 20239/9 normalizedLevel 3Jun 30, 20239/9 normalizedLevel 3Sep 30, 20239/9 normalizedLevel 3Sep 30, 20269/9 normalizedLevel 4
Period transition
What moved in the state?
- Previous
- 10.77%
- Current
- 9.02%
- Delta
- -1.75%
- Previous
- 0.83%
- Current
- 19.64%
- Delta
- 18.81%
- Previous
- 1.57%
- Current
- 1.69%
- Delta
- 0.12%
- Previous
- 7.80%
- Current
- 7.87%
- Delta
- 0.07%
- Previous
- 53.60%
- Current
- 50.95%
- Delta
- -2.65%
- Previous
- 34.05%
- Current
- 34.36%
- Delta
- 0.30%
- Previous
- 8.29%
- Current
- 15.77%
- Delta
- 7.49%
- Previous
- 2.60%
- Current
- 2.27%
- Delta
- -0.33%
- Previous
- 1.27%
- Current
- 1.26%
- Delta
- -0.01%
Self-history only
Previous similar states
Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research
Transitioned To · WST Fundamental State →Analogous To · WST state analogue 5 →Transitioned To · WST Fundamental State →Transitioned To · WST CAPEX_INTENSITY_DECREASED →Transitioned To · WST CASH_GENERATION_INCREASED →Transitioned To · WST DILUTION_INCREASED →Transitioned To · WST GROWTH_INCREASED →Transitioned To · WST INVENTORY_PRESSURE_DECREASED →Transitioned To · WST MARGIN_INCREASED →Transitioned To · WST PROFITABILITY_INCREASED →Transitioned To · WST R_AND_D_INTENSITY_DECREASED →Transitioned To · WST SBC_INTENSITY_DECREASED →
Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.